Pharmac seeks suppliers for rituximab, infliximab, and tocilizumab in New Zealand.
Pharmac, the New Zealand pharmaceutical management agency, invites proposals for the supply of three biologic drugs: rituximab, infliximab, and tocilizumab. The RFP includes detailed schedules on background, process, estimated market size, and standard terms. Proposals must be submitted via GETS by 2 September 2026. An online supplier briefing will be held on 4 August 2026. This is a national procurement for the New Zealand market.
Open the official notice for the full requirements, documents and submission details.